Insulin, Sodium-Lithium Countertransport, and Microalbuminuria in Hypertensive Patients

Hypertension

Volumn 31, Issue 1, 1998, Pages 110-113

  Andronico, Giuseppe ^a   Ferrara, Lidia ^a   Mangano, Mariateresa ^a   Mule, Giuseppe ^a   Cerasola, Giovanni ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; INSULIN; LITHIUM;

ADULT; ARTICLE; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; SODIUM TRANSPORT;

ALBUMINURIA; BIOLOGICAL TRANSPORT, ACTIVE; FEMALE; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; LITHIUM; MALE; SODIUM;

EID: 0031915408     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.31.1.110     Document Type: Article

References (38)

1. Mogensen CE. Microalbuminuria as predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Kidney Int. 1987;31:673-689.
2. Mattock MB, Morrish NJ, Viberti GC, Keen H, Fitzgerald AO, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes. 1992;41:736-741.
3. Mattock MB, Keen R, Viberti G. Coronary heart disease and urinary albumin excretion rate in type II diabetic patients. Diabetologia. 1988;31:82-87.
4. Cerasola G, Cottone S, D'Ignoto G, Grasso G, Mangano MT, Andronico G. Microalbuminuria points out early renal and cardiovascular damage in essential hypertension. Rev Latina Cardiol. 1992;13:15-21.
5. Cerasola G, Cottone S, D'lgnoto G, Grasso L, Mangano MT, Andronico G. Microalbuminuria as predictor of cardiovascular damage in essential hypertension. J Hypertens. 1989;7(suppl 7):S332-S333.
6. Yudkin JS, Forre RD, Jackson CA. Microalbuminuria as a predictor of vascular disease in non-diabetic subjects. Lancet. 1988;2:531-534.
7. Krowlesky AS, Canessa M, Warram JH, Lattel LMB, Christlief AR, Knowler WC, Rand LI. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med. 1988;318:140-145.
8. Mangili R, Bending JJ, Scott G, Li LK, Viberti G. Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes mellitus. N Engl J Med. 1988;318:146-150.
9. Nosadini R, Semplicini A, Fioretto P, Lusiani L, Trevisan R, Donadon V, Zanette G, Nicolosi GL, Dell'Aglio V, Zanuttini D, Viberti GC. Sodium-lithium countertransport and cardiovascular abnormalities in essential hypertension. Hypertension. 1991;18:191-198.
10. Andronico G, Nardi E, Mangano MT, Piazza G, Cerasola G. Sodium-lithium countertransport and left ventricular mass in essential hypertension. J Hum Hypertens. 1992;6(suppl):249. Abstract.
11. Canessa M, Falkner B, Hulman S. Red blood cell sodium-proton exchange in hypertensive blacks with insulin-resistant glucose disposal. Hypertension. 1993;22:204-213.
12. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988; 37:1595-1607.
13. Bianchi S, Bigazzi R, Valtriani C, Chiapponi I, Sgherri G, Baldari G, Natali A, Ferranini E, Campese VM. Elevated serum insulin levels in patients with essential hypertension and microalbuminuria. Hypertension. 1994;23:681-687.
14. Canessa M, Adragna N, Solomon HS, Connolly TM, Tosteson DC. Increased sodium-lithium countertransport activity in red cells of patients with essential hypertension. N Engl J Med. 1980;302:769-771.
15. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 1984;310:356-360.
16. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J. A prospective population-based study of microalbuminuria as a predictor of mortality in NIIDM. Diabetes Care. 1993;16:996-1003.
17. Damsgaard ME, Froland A, Jorgensen DO, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. BMJ. 1990;330:297-300.
18. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet. 1988;2:530-533.
19. Haffner SM, Stern MP, Gruber G, Hazuda HP, Mitchell BD, Patterson JK. Microalbuminuria: potential marker for increased cardiovascular risk factor in nondiabetic subjects? Arteriosclerosis. 1990;5:727-731.
20. Cerasola G, Cottone S, Mule G, Nardi E, Mangano MT, Andronico G, Contorno A, Li Vecchi M, Galione P, Renda F, Piazza G, Volpe V, Lisi A, Ferrara L, Panepinto N, Riccobene R. Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension. J Hypertens. 1996;14:915-920.
21. Canessa ML, Morgan K, Semplicini A. Genetic differences in lithium-sodium exchange and regulation of the sodium-hydrogen exchanger in essential hypertension. J Cardiovasc Pharmacol. 1989;12(suppl 3):S92-S98.
22. Hardman TC, Lant AF. Controversies surrounding erythrocyte sodium-lithium countertransport. J Hypertens. 1996;14:695-703.
23. Krezinski JM, Saint-Remy A, Du F, Rorive G. Red blood cell Na-Li countertransport, hypertensive heredity, and cardiovascular risk in young adults. Am J Hypertens. 1993;6:314-316.
24. Andronico G, Nardi E, Mangano MT, Piazza G, Cerasola G. Sodium-lithium countertransport and left ventricular mass in essential hypertension. J Hum Hypertens. 1992;6(suppl):249. Abstract.
25. Yap L, Arrazola A, Soria F, Diez J. Is there increased cardiovascular risk in essential hypertensive patients with abnormal kinetics of red blood cell sodium-lithium countertransport? Hypertens. 1989;7:667-673.
26. Mongeau JG, Mauran P, Poirot G, Davignon A. Longitudinal study of various transport abnormalities as an index of severity in children and adolescent suffering from essential hypertension. J Hypertens. 1990;8:657-662.
27. Laurenzi M, Trevisan M. Sodium-lithium countertransport and blood pressure: the Gubbio population study. Hypertension. 1989;13:408-415.
28. Schieken RM. Genetic factors that predispose the child to develop hypertension. Ped Clin N Am. 1993;40:1-11.
29. Rebbeck TR, Turner ST, Sing CF. Sodium-lithium countertransport genotype and the probability of hypertension in adults. Hypertension. 1993;22:560-568.
30. Williams RR, Hasstedt SJ, Hunt SC, Wu LL, Ash KD. Genetic studies of cation tests and hypertension. Hypertension. 1987;10(suppl I):I-37-I-41.
31. Kurtz TW. Genetic models of hypertension. Lancet. 1994;344:167-168.
32. Schmidt S, Ganten D. Genetics of primary hypertension. Nephrol Dial Transplant. 1994;9:473-474.
33. Lindpaintner K. Genes, hypertension, and cardiac hypertrophy. N Engl J Med. 1994;23:1678-1679.
34. Yip JW, Jones C, Facchini F, Chen I, Reaven GM. Insulin resistance in patients with essential hypertension can occur in the absence of microalbuminuria. Am J Hypertens. 1996;9:959-963.
35. Giampietro O, Matteucci E, Catapano G, Dell'Omo G, Talarico L, Di Muro C, Di Bello V, Pedrinelli R. Microalbuminuria and erythrocyte sodium-hydrogen exchange in essential hypertension. Hypertension. 1995;25:981-985.
36. Turner ST, Rebbeck TR, Sing CF. Sodium-lithium countertransport and probability of hypertension in Caucasians 47 to 89 years old. Hypertension. 1992;20:841-850.
37. Turner ST, Sing CF. Erythrocyte sodium transport and the probability of having hypertension. J Hypertens. 1996;14:829-837.
38. Falkner B, Kushner H, Levison S, Canessa M. Albuminuria in association with insulin and sodium-lithium countertransport in young African Americans with borderline hypertension. Hypertension. 1995;25:1315-1321.